Latest Articles

Publication Date
All News Scientific
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Clinical Trials Arena

Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena

Published: June 10, 2025, 9:06 a.m.
Read Full Article
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - Physician's Weekly

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer Physician's Weekly

Published: June 10, 2025, 6:31 a.m.
Read Full Article
ASCO 2025: Key Highlights in Endometrial and Related Cancers - Medscape

ASCO 2025: Key Highlights in Endometrial and Related Cancers Medscape

Published: June 9, 2025, 9:21 p.m.
Read Full Article
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - HealthDay

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer HealthDay

Published: June 9, 2025, 2:50 p.m.
Read Full Article
AZN Initiates Phase 3 Trial for Enhertu in Advanced Endometrial Cancer | AZN Stock News - GuruFocus

AZN Initiates Phase 3 Trial for Enhertu in Advanced Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:46 p.m.
Read Full Article
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - BioSpace

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer BioSpace

Published: June 9, 2025, 12:43 p.m.
Read Full Article
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News - GuruFocus

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:18 p.m.
Read Full Article
Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News - Stock Titan

Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News Stock Titan

Published: June 9, 2025, noon
Read Full Article
How robotic surgeries are offering safer, quicker, more precise care for gynaecological cancers - The Hindu

How robotic surgeries are offering safer, quicker, more precise care for gynaecological cancers The Hindu

Published: June 9, 2025, 9:03 a.m.
Read Full Article
Obesity-induced inflammation plays a crucial role in endometrial cancer... - researchgate.net

Obesity-induced inflammation plays a crucial role in endometrial cancer... researchgate.net

Published: June 9, 2025, 1:53 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!